Terms: = Skin cancer AND ATP2B3, PMCA3, 492, ENSG00000067842
81 results:
1. Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
Steadman JA; Glasgow AE; Neequaye NN; Habermann EB; Hieken TJ
J Surg Oncol; 2024 May; 129(6):1041-1050. PubMed ID: 38436625
[TBL] [Abstract] [Full Text] [Related]
2. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
3. Implementation of Supportive Care Program to Decrease CLABSI in a Middle East Pediatric Hematology and Oncology Inpatient Unit.
Thompson K; Shaheen M
J Pediatr Hematol Oncol Nurs; 2023; 40(5):313-324. PubMed ID: 37920979
[No Abstract] [Full Text] [Related]
4. The effect of gel pads on the measurement of breast superficial lesions by shear wave elastography.
Zhang Z; He S; Zhong Y; Zou H; Cai L; Zhang Y; Wang H
Ann Med; 2023; 55(2):2269941. PubMed ID: 37871181
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
[TBL] [Abstract] [Full Text] [Related]
6. Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial.
Kent P; Haines T; O'Sullivan P; Smith A; Campbell A; Schutze R; Attwell S; Caneiro JP; Laird R; O'Sullivan K; McGregor A; Hartvigsen J; Lee DA; Vickery A; Hancock M;
Lancet; 2023 Jun; 401(10391):1866-1877. PubMed ID: 37146623
[TBL] [Abstract] [Full Text] [Related]
7. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC
JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292
[TBL] [Abstract] [Full Text] [Related]
8. Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance.
Brown H; De'Ambrosis B; Yong-Gee S; Griffin A; Muir J
Australas J Dermatol; 2023 May; 64(2):234-241. PubMed ID: 36774586
[TBL] [Abstract] [Full Text] [Related]
9. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.
Allen I; Hassan H; Sofianopoulou E; Eccles D; Turnbull C; Tischkowitz M; Pharoah P; Antoniou AC
Breast Cancer Res; 2023 Feb; 25(1):18. PubMed ID: 36765408
[TBL] [Abstract] [Full Text] [Related]
10. Vitamin D knowledge and sun exposure practices among Sri Lankan healthcare undergraduates.
Liyanage G; Jayathunga S; Amarasekara T
PLoS One; 2022; 17(12):e0279480. PubMed ID: 36574411
[TBL] [Abstract] [Full Text] [Related]
11. Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
Watson AS; Goutam S; Stukalin I; Ewanchuk BW; Sander M; Meyers DE; Pabani A; Cheung WY; Heng DYC; Cheng T; Monzon JG; Navani V
JAMA Netw Open; 2022 Dec; 5(12):e2245596. PubMed ID: 36480204
[TBL] [Abstract] [Full Text] [Related]
12. Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study): An International Phase III Randomized Clinical Trial.
Moncrieff MD; Bastiaannet E; Underwood B; Francken AB; Garioch J; Damude S; Heaton M; Deckers EA; Patel N; Hoekstra-Weebers JE; Hoekstra HJ
Ann Surg; 2022 Oct; 276(4):e208-e216. PubMed ID: 35866644
[TBL] [Abstract] [Full Text] [Related]
13. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma.
Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M
PeerJ; 2022; 10():e12646. PubMed ID: 35116193
[TBL] [Abstract] [Full Text] [Related]
14. Eruptive Seborrheic Keratoses Are Associated With a Co-Occurring Malignancy in the Majority of Reported Cases: A Systematic Review.
Mirali S; Mufti A; Lansang RP; Sachdeva M; Yeung J
J Cutan Med Surg; 2022; 26(1):57-62. PubMed ID: 34841905
[TBL] [Abstract] [Full Text] [Related]
15. Residential extremely low frequency magnetic fields and skin cancer.
Khan MW; Juutilainen J; Naarala J; Roivainen P
Occup Environ Med; 2022 Jan; 79(1):49-54. PubMed ID: 34593542
[TBL] [Abstract] [Full Text] [Related]
16. Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma.
Gao G; Yao Z; Shen J; Liu Y
Biomed Res Int; 2021; 2021():5524486. PubMed ID: 33880366
[TBL] [Abstract] [Full Text] [Related]
17. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract] [Full Text] [Related]
18. Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
Millán-Esteban D; García-Casado Z; Manrique-Silva E; Virós A; Kumar R; Furney S; López-Guerrero JA; Requena C; Bañuls J; Traves V; Nagore E
Eur J Dermatol; 2021 Dec; 31(6):830-838. PubMed ID: 33648909
[TBL] [Abstract] [Full Text] [Related]
19. Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.
Zhao S; Tang L; Chen W; Su J; Li F; Chen X; Wu L
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):797-807. PubMed ID: 33009925
[TBL] [Abstract] [Full Text] [Related]
20. Clinicoprognostic characteristics of cutaneous metastatic melanoma: a retrospective comparative study between acral and nonacral melanoma.
Kang HJ; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Int J Dermatol; 2020 Oct; 59(10):1249-1257. PubMed ID: 32720336
[TBL] [Abstract] [Full Text] [Related]
[Next]
